<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { padding-top: 0 ; padding-bottom: 0 }
--></style><title>Fwd: Undergrad Lunch with David Berry, Feb.
12</title></head><body>
<blockquote type="cite" cite>Date: Fri, 05 Feb 2010 17:19:14
-0500</blockquote>
<blockquote type="cite" cite>From: Dima Ter-Ovanesyan
<dter@MIT.EDU></blockquote>
<blockquote type="cite" cite>Subject: Undergrad Lunch with David
Berry, Feb. 12</blockquote>
<blockquote type="cite" cite><br>
Biomatrix and Biology Undergraduate Student Association (BUSA)
Present:<br>
<br>
Leaders in the Life Science Industry Lunch Series<br>
<br>
Lunch with David Berry, MD, PhD, Partner at Flagship Ventures<br>
<br>
Learn about Entrepreneurship in the life sciences and the application
of<br>
synthetic biology to the energy problem from an MIT Alum (full bio
below).<br>
<br>
Date: Friday, February 12<br>
Time: 12:00-1:00 PM<br>
<br>
Open to undergrads of all majors.<br>
<br>
Space is limited. RSVP to dter@mit.edu<br>
<br>
Bio:<br>
David Berry is a Partner at Flagship Ventures, having joined Flagship
in 2005<br>
while completing his M.D. from Harvard Medical School. David was
previously<br>
awarded a Ph.D. through the MIT Biological Engineering Division, where
he<br>
studied the biological effects of complex sugars with advisors
Professor Ram<br>
Sasisekharan and Professor Robert Langer. David also did his
undergraduate work<br>
at MIT, graduating in 2000 Phi Beta Kappa and Sigma Xi, with a degree
in brain<br>
and cognitive sciences. He was named as a member of the MIT
Corporation - its<br>
Board of Trustees - in 2006. David's work has led to 11
peer-reviewed<br>
publications, over 20 patents and applications, as well as over
twenty-five<br>
awards and honors including the prestigious Lemelson-MIT Student Prize
in 2005<br>
for invention and innovation. David was also named as the Innovator of
the Year<br>
by Technology Review in its 2007 TR35 list of world?s top 35
innovators under<br>
the age of 35.<br>
<br>
At Flagship, David focuses on investing in and founding early stage
life science<br>
and cleantech ventures. In 2005, he co-founded and helped launch LS9,
and more<br>
recently co-founded Joule Biotechnologies where he previously served
as the<br>
founding CEO. In addition, David serves on the Board of Directors of
CGI<br>
Pharmaceuticals and works closely with several other portfolio
companies.<br>
<br>
<br>
<br>
<br>
<br>
<br>
----- End forwarded message -----<br>
</blockquote>
<blockquote type="cite" cite>Biomatrix and Biology Undergraduate
Student Association (BUSA) Present:<br>
<br>
Leaders in the Life Science Industry Lunch Series<br>
<br>
Lunch with David Berry, MD, PhD, Partner at Flagship Ventures<br>
<br>
Learn about Entrepreneurship in the life sciences and the application
of<br>
synthetic biology to the energy problem from an MIT Alum (full bio
below).<br>
<br>
Date: Friday, February 12<br>
Time: 12:00-1:00 PM<br>
<br>
Open to undergrads of all majors.<br>
<br>
<b>Space is limited. RSVP to </b><a
href="mailto:dter@mit.edu"><b>dter@mit.edu</b></a><b><br>
</b><br>
Bio:<br>
David Berry is a Partner at Flagship Ventures, having joined Flagship
in 2005<br>
while completing his M.D. from Harvard Medical School. David was
previously<br>
awarded a Ph.D. through the MIT Biological Engineering Division, where
he<br>
studied the biological effects of complex sugars w! ith advisors
Professor Ram<br>
Sasisekharan and Professor Robert Langer. David also did his
undergraduate work<br>
at MIT, graduating in 2000 Phi Beta Kappa and Sigma Xi, with a degree
in brain<br>
and cognitive sciences. He was named as a member of the MIT
Corporation - its<br>
Board of Trustees - in 2006. David's work has led to 11
peer-reviewed<br>
publications, over 20 patents and applications, as well as over
twenty-five<br>
awards and honors including the prestigious Lemelson-MIT Student Prize
in 2005<br>
for invention and innovation. David was also named as the Innovator of
the Year<br>
by Technology Review in its 2007 TR35 list of world?s top 35
innovators under<br>
the age of 35.<br>
<br>
At Flagship, David focuses on investing in and founding early stage
life science<br>
and cleantech ventures. In 2005, he co-founded and helped launch LS9,
and more<br>
recently co-founded Joule Biotechnologies where he previously served
as the<br>
founding CEO. In addition, David serves on the ! Board of Directors of
CGI<br>
Pharmaceuticals and works closely! with se veral other portfolio
companies.<br>
</blockquote>
<blockquote type="cite" cite><br></blockquote>
<div><br></div>
</body>
</html>